Risk factor
Very poor trading liquidity
Profitability factor
Excellent dividends
About
Ladprao General Hospital Public Company Limited, including its subsidiaries, functions as a prominent healthcare provider in Thailand, primarily through the operation of the private Ladprao General Hospital. This facility offers an extensive range of medical specialties, such as neurology, cardiology, hypertension management, dentistry, hemodialysis, pediatrics, refractive eye surgery, women's health, aesthetic and dermatological services, laser treatments, and ear, nose, and throat care. The hospital also hosts specialized centers for health screenings, gastroenterology, hepatology, orthopedics, physical therapy, and rehabilitation. Expanding beyond direct patient care, the company delivers scientific analytical and diagnostic services for industries including food, agriculture, pharmaceuticals, and environmental protection. It further conducts instrument calibration, quality inspections, and provides certifications that adhere to stringent quality systems and international benchmarks. Other ventures include hospital management and consulting, mobile health check-ups, and professional nursing services for industrial sites and other organizations. Moreover, the company actively researches, develops, cultivates, and distributes herbal products with medicinal benefits. Established in 1990, Ladprao General Hospital Public Company Limited is headquartered in Bangkok, Thailand.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, underpriced on P/FCF.